Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine Butyrate + Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
NCT00917826Phase 2Terminated
- Sponsor
- HemaQuest Pharmaceuticals, Inc.
- Start
- Sep 2008
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of arginine butyrate in lymphoid malignancies, sponsored by HemaQuest Pharmaceuticals, Inc.. Started Sep 2008; status: terminated.
02
Drugs
arginine butyrate
03
Conditions
lymphoid malignancies
Beyond the preview
Go deeper on NCT00917826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917826.